TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
DrugtestScandinavia AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
252
|
210
|
170 |
| Financial expenses |
0
|
3
|
0 |
| Earnings before taxes |
-28
|
-2
|
14 |
| EBITDA |
-29
|
0
|
13 |
| Total assets |
120
|
172
|
167 |
| Current assets |
120
|
149
|
162 |
| Current liabilities |
111
|
73
|
53 |
| Equity capital |
9
|
99
|
110 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
7.5%
|
57.6%
|
65.9% |
| Turnover per employee |
126
|
105
|
85 |
| Profit as a percentage of turnover |
-11.1%
|
-1.0%
|
8.2% |
| Return on assets (ROA) |
-23.3%
|
0.6%
|
8.4% |
| Current ratio |
108.1%
|
204.1%
|
305.7% |
| Return on equity (ROE) |
-311.1%
|
-2.0%
|
12.7% |
| Change turnover |
42
|
53
|
-4 |
| Change turnover % |
20%
|
34%
|
-2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.